We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+19.59%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.49B
AUM Growth
+$149M
Cap. Flow
-$38.7M
Cap. Flow %
-1.56%
Top 10 Hldgs %
20.52%
Holding
268
New
26
Increased
99
Reduced
104
Closed
25

Sector Composition

1 Technology 25.01%
2 Healthcare 24.99%
3 Industrials 19.42%
4 Financials 9.95%
5 Consumer Discretionary 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMCI icon
1
Super Micro Computer
SMCI
$15.6B
$90.6M 3.64%
896,800
-643,190
-42% -$47.1M
FRPT icon
2
Freshpet
FRPT
$2.78B
$65.6M 2.64%
566,116
+3,648
+0.6% +$353K
FTAI icon
3
FTAI Aviation
FTAI
$21.3B
$58.1M 2.34%
862,750
+13,814
+2% +$758K
VRNS icon
4
Varonis Systems
VRNS
$5.46B
$47.5M 1.91%
1,007,989
+53,537
+6% +$2.55M
CRS icon
5
Carpenter Technology
CRS
$27.7B
$44.5M 1.79%
622,959
-51,601
-8% -$3.38M
TENB icon
6
Tenable Holdings
TENB
$4.4B
$42.8M 1.72%
865,590
+19,388
+2% +$921K
GTLS icon
7
Chart Industries
GTLS
$42M 1.69%
255,194
+3,164
+1% +$425K
CHDN icon
8
Churchill Downs
CHDN
$5.85B
$40.8M 1.64%
330,048
+7,797
+2% +$942K
LIVN icon
9
LivaNova
LIVN
$4.43B
$39.5M 1.59%
705,297
+216,861
+44% +$11.3M
TMDX icon
10
Transmedics
TMDX
$2.56B
$38.7M 1.56%
523,420
+7,067
+1% +$582K
BPMC
11
DELISTED
Blueprint Medicines
BPMC
$38.2M 1.54%
402,910
-63,516
-14% -$5.45M
PLMR icon
12
Palomar
PLMR
$3.59B
$37.7M 1.52%
449,989
+4,658
+1% +$319K
ATI icon
13
ATI
ATI
$25.4B
$36.3M 1.46%
708,860
+151,471
+27% +$6.85M
TNET icon
14
TriNet
TNET
$2.74B
$34.5M 1.39%
260,199
+16,052
+7% +$1.95M
KTOS icon
15
Kratos Defense & Security Solutions
KTOS
$8.63B
$33.6M 1.35%
1,830,548
+23,798
+1% +$434K
QTWO icon
16
Q2 Holdings
QTWO
$3.43B
$32.8M 1.32%
624,317
+232,483
+59% +$10.5M
RDNT icon
17
RadNet
RDNT
$4.89B
$32.6M 1.31%
670,979
+122,348
+22% +$4.93M
PDFS icon
18
PDF Solutions
PDFS
$2.14B
$30.7M 1.24%
913,232
+158,376
+21% +$5.19M
CRDO icon
19
Credo Technology Group
CRDO
$37.8B
$30.7M 1.24%
1,448,790
+258,779
+22% +$5.42M
SKWD icon
20
Skyward Specialty Insurance
SKWD
$2.4B
$30.6M 1.23%
817,300
+27,727
+4% +$938K
ACAD icon
21
Acadia Pharmaceuticals
ACAD
$4.38B
$30.5M 1.23%
1,651,124
+5,559
+0.3% +$138K
AVAV icon
22
AeroVironment
AVAV
$7.2B
$30.3M 1.22%
197,818
-31,226
-14% -$4.17M
NEO icon
23
NeoGenomics
NEO
$1.9B
$30M 1.21%
1,905,904
+8,090
+0.4% +$125K
MMSI icon
24
Merit Medical Systems
MMSI
$4.41B
$28.2M 1.13%
372,292
+681
+0.2% +$52.6K
ONT
25
Onterris Inc
ONT
$756M
$28.1M 1.13%
718,618
+8,157
+1% +$273K

Similar funds

Emerald Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Emerald Advisers held 268 positions worth $2.49B, up 6.4% from $2.34B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Emerald Advisers's Q1 2024 filing shows 26 new, 99 increased, 104 reduced and 25 closed positions. Its largest new stake was Louisiana-Pacific: 276,306 shares worth $23.2M. The largest sale was Immunogen Inc, an estimated $51.7M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Emerald Advisers's largest Q1 2024 buy was Louisiana-Pacific: 276,306 shares worth $23.2M.
  • Emerald Advisers added most to Madrigal Pharmaceuticals in Q1 2024, an estimated $12.7M increase.
  • Emerald Advisers's biggest Q1 2024 reduction was Super Micro Computer, cutting an estimated $47.1M.
  • Emerald Advisers fully exited Immunogen Inc in Q1 2024, selling an estimated $51.7M.
  • Emerald Advisers's ten largest holdings make up 21% of its $2.49B portfolio in Q1 2024.
  • Emerald Advisers opened 26 new positions and closed 25 in Q1 2024.
  • Emerald Advisers's portfolio value rose 6.4% quarter-over-quarter to $2.49B.

Based on Emerald Advisers's 13F filing for Q1 2024, filed 8 May 2024.